Original articleSynthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors

Add time:09/25/2019    Source:sciencedirect.com

A novel series of piperidine-substituted triazine derivatives have been synthesized and evaluated for anti-HIV activities in MT-4 cells. Most compounds displayed extremely promising activity against wild-type HIV-1 with EC50 values in low nanomolar concentration, better than that of Nevirapine, Delavirdine, Zidovudine and Dideoxycitidine, and higher potency towards the resistant mutant strain K103N/Y181C than that of Nevirapine and Delavirdine. Selected compounds were also assayed against reverse transcriptase with lower IC50 values than that of Nevirapine. The structure-activity relationship (SAR) of these novel structural congeners was also discussed.

We also recommend Trading Suppliers and Manufacturers of 1-(2-NITROPHENYL)PIPERIDINE (cas 15822-77-2). Pls Click Website Link as below: cas 15822-77-2 suppliers

Prev:Secondary amine-catalyzed asymmetric formal aza [3 + 3] cycloaddition to construct enantioenriched piperidines derivatives
Next:ReviewFragrance material review on (4-methoxyphenyl)methyl isobutyrate)